Women Who Conquer Cancer
Women Who Conquer Cancer
The 2022 OncoAlert Colloquium Day 6: EONS Sessions
Optimisation of supportive, palliative and end of life care
What is required to advance data ethics, data sharing, and Open Science across LMICs
Access to Oncology Medicines Coalition - The Medicines Patent Pool
Tislelizumab demonstrates non-inferior OS compared to sorafenib for treating hepatocellular carcinoma
Intraoperative Radiotherapy
Cancer survivors' stories: An African perspective
ESMO 2022: Highlights, commentary and analysis
Adjuvant nivolumab plus ipilimumab vs placebo for localised renal cell carcinoma at high risk of relapse after nephrectomy
A new era of early cancer detection with blood test may change cancer screening paradigms
Nivolumab ipilimumab combo does not improve DFS for RCC after nephrectomy